←
Annals of the Rheumatic Diseases5,782 posts
Annals of the Rheumatic Diseases avatar

Annals of the Rheumatic Diseases

@eular_ARD

Annals of the Rheumatic Diseases (#1 research journal in Rheumatology). High quality, peer reviewed research.

◷ Joined April 2010▧ 2,309 Photos and videos
Annals of the Rheumatic Diseases avatar
Annals of the Rheumatic Diseases@eular_ARD·Jun 6

#EULAR2026: Treating PH in CTD (Allanore) Novel disease-modifying drug → sotatercept (TGF-β/activin pathway), can reverse pulmonary vascular remodeling. Unlike idiopathic #PAH, CTD-PAH has an autoimmune component → treat the disease + the pulmonary vasculature. @ElvisHysa

Post attachmentPost attachmentPost attachment
Annals of the Rheumatic Diseases avatar
Annals of the Rheumatic Diseases@eular_ARD·Jun 5

#EULAR2026 debate: To (Re)biopsy or Not in ANCA-Associated Vasculitis? ⚖️ Jayne (Pro): biopsy stays guideline-recommended: diagnosis, prognosis & drug selection ⚖️ Tomelleri (Contra): renal biopsy may be replaced by biomarkers (usCD163, uMCP-1, uEGF) and imaging @ElvisHysa

Post attachmentPost attachmentPost attachment
Annals of the Rheumatic Diseases avatar
Annals of the Rheumatic Diseases@eular_ARD·Jun 5

🧬 #EULAR2026 Systemic Sclerosis, by Oliver Distler Cell-based & T-cell engaging therapies enter refractory SSc: 🔹 CAR-T: median pFVC +6.4% at 6m (BREAKFREE-1) 🔹 BCMA-TCE teclistamab: ↓mRSS & tendon friction rubs (Nat Med 2026) Beyond conventional IS. #SSc @ElvisHysa

Post attachmentPost attachmentPost attachmentPost attachment
Annals of the Rheumatic Diseases avatar
Annals of the Rheumatic Diseases@eular_ARD·Jun 4

#EULAR2026: GCA & Takayasu, Shared Pathways, Different Ages? Two prototypes, one spectrum. TAK: CD8+ cytotoxic injury, prominent fibrosis GCA: macrophage-driven, self-renewing lesions Shared IL-6/JAK response; TNFi only in TAK from Weyand, Tomelleri, Direskeneli @ElvisHysa

Post attachmentPost attachmentPost attachment